Article
Fixed-combination drug beneficial in glaucoma therapy
The fixed combination of timolol-dorzolamide (Cosopt, Merck) can be beneficial in glaucoma therapy for several reasons: prescribed in conjunction with a single agent such as a prostaglandin analog, it may achieve a greater reduction in the patient's IOP than the single agent alone, and it can improve compliance, according to two glaucoma experts.
Related Videos
Related Content
